140 related articles for article (PubMed ID: 20095795)
21. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
Farley A; Wruble LD; Humphries TJ
Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
[TBL] [Abstract][Full Text] [Related]
22. Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.
Fass R; Inadomi J; Han C; Mody R; O'Neil J; Perez MC
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):247-53. PubMed ID: 22155561
[TBL] [Abstract][Full Text] [Related]
23. Review article: the management of heartburn in pregnancy.
Richter JE
Aliment Pharmacol Ther; 2005 Nov; 22(9):749-57. PubMed ID: 16225482
[TBL] [Abstract][Full Text] [Related]
24. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
[TBL] [Abstract][Full Text] [Related]
25. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
Sontag SJ
Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness and cost-utility of long-term management strategies for heartburn.
Goeree R; O'Brien BJ; Blackhouse G; Marshall J; Briggs A; Lad R
Value Health; 2002; 5(4):312-28. PubMed ID: 12102694
[TBL] [Abstract][Full Text] [Related]
27. Treatment of heartburn and acid reflux associated with nausea and vomiting during pregnancy.
Law R; Maltepe C; Bozzo P; Einarson A
Can Fam Physician; 2010 Feb; 56(2):143-4. PubMed ID: 20154244
[TBL] [Abstract][Full Text] [Related]
28. Review article: the management of heartburn during pregnancy and lactation.
Thélin CS; Richter JE
Aliment Pharmacol Ther; 2020 Feb; 51(4):421-434. PubMed ID: 31950535
[TBL] [Abstract][Full Text] [Related]
29. Implications of over-the-counter proton pump inhibitors for patient counseling by pharmacists.
Simonson W
Am J Ther; 2013; 20(6):676-84. PubMed ID: 21642828
[TBL] [Abstract][Full Text] [Related]
30. Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?
Kushner PR; Peura DA
Adv Ther; 2011 May; 28(5):367-88. PubMed ID: 21484335
[TBL] [Abstract][Full Text] [Related]
31. Management of heartburn: cost considerations.
Vakil N
Postgrad Med; 2000 May; 107(5 Suppl):35-8; discussion 39. PubMed ID: 19667513
[No Abstract] [Full Text] [Related]
32. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
33. Refractory Heartburn: A Challenging Problem in Clinical Practice.
Domingues G; Moraes-Filho JPP; Fass R
Dig Dis Sci; 2018 Mar; 63(3):577-582. PubMed ID: 29352757
[TBL] [Abstract][Full Text] [Related]
34. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
Shimatani T; Sugimoto M; Nishino M; Adachi K; Furuta K; Ito M; Kurosawa S; Manabe N; Mannen K; Hongo M; Chiba T; Kinoshita Y;
J Gastroenterol Hepatol; 2012 May; 27(5):899-906. PubMed ID: 22098590
[TBL] [Abstract][Full Text] [Related]
35. Treating Gastroesophageal Reflux and Heartburn While Breastfeeding.
Anderson PO
Breastfeed Med; 2018 Sep; 13(7):463-464. PubMed ID: 30074826
[No Abstract] [Full Text] [Related]
36. [Therapy of gastroesophageal reflux disease (GERD)].
Storr M
Med Monatsschr Pharm; 2011 Dec; 34(12):446-54; quiz 455-6. PubMed ID: 22233024
[TBL] [Abstract][Full Text] [Related]
37. 24-hour ambulatory pH-metry in patients with refractory heartburn: a prospective study.
Talaie R; Forootan M; Donboli K; Dadashzadeh N; Sadeghi A; Poorsaadat S; Moghimi B; Mohammad Alizadeh AH; Zali MR
J Gastrointestin Liver Dis; 2009 Mar; 18(1):11-5. PubMed ID: 19337627
[TBL] [Abstract][Full Text] [Related]
38. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
39. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.
Kandulski A; Jechorek D; Caro C; Weigt J; Wex T; Mönkemüller K; Malfertheiner P
Aliment Pharmacol Ther; 2013 Sep; 38(6):643-51. PubMed ID: 23895770
[TBL] [Abstract][Full Text] [Related]
40. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]